• Beaudet AL. 2010. Which way for genetic-test regulation? Leave test interpretation to specialists. Nature 466:816817.
  • Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD, Sheth V, Woodward JE, and many other. 2011. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 3:65ra4.
  • Berger AH, Knudson AG, Pandolfi PP. 2011. A continuum model for tumour suppression. Nature 476:163169.
  • Branicki W, Liu F, van Duijn K, Draus-Barini J, Pospiech E, Walsh S, Kupiec T, Wojas-Pelc A, Kayser M. 2011. Model-based prediction of human hair color using DNA variants. Hum Genet 129:443454.
  • Hoischen A, van Bon BW, Gilissen C, Arts P, van Lier B, Steehouwer M, de Vries P, de Reuver R, Wieskamp N, Mortier G, Devriendt K, Amorim MZ, and many others. 2010. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet 42:483485.
  • Hoischen A, van Bon BW, Rodriguez-Santiago B, Gilissen C, Vissers LE, de Vries P, Janssen I, van Lier B, Hastings R, Smithson SF, Newbury-Ecob R, Kjaergaard S, and many others. 2011. De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome. Nat Genet 43:729731.
  • Huang CR, Schneider AM, Lu Y, Niranjan T, Shen P, Robinson MA, Steranka JP, Valle D, Civin CI, Wang T, Wheelan SJ, Ji H, and many others. 2010. Mobile interspersed repeats are major structural variants in the human genome. Cell 141:11711182.
  • Iskow RC, McCabe MT, Mills RE, Torene S, Pittard WS, Neuwald AF, Van Meir EG, Vertino PM, Devine SE. 2010. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 141:12531261.
  • Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW, Lin JC, Palmisano E, Brune K, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, and many others. 2009. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324:217.
  • Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, and many others. 2008. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:18011806.
  • Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, Vedantam S, Raychaudhuri S, Ferreira T, Wood AR, and many others. 2010. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467:832838.
  • Link DC, Schuettpelz LG, Shen D, Wang J, Walter MJ, Kulkarni S, Payton JE, Ivanovich J, Goodfellow PJ, Le Beau M, Koboldt DC, Dooling DJ, and many others. 2011. Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML. JAMA 305:15681576.
  • Liu F, van Duijn K, Vingerling JR, Hofman A, Uitterlinden AG, Janssens AC, Kayser M. 2009. Eye color and the prediction of complex phenotypes from genotypes. Curr Biol 19:R192R193.
  • Liu F, Wollstein A, Hysi PG, Ankra-Badu GA, Spector TD, Park D, Zhu G, Larsson M, Duffy DL, Montgomery GW, Mackey DA, Walsh S, and many others. 2010. Digital quantification of human eye color highlights genetic association of three new loci. PLoS Genet 6:e1000934.
  • Lupski JR, Belmont JW, Boerwinkle E, Gibbs RA. 2011. Clan genomics and the complex architecture of human disease. Cell 147:3243.
  • Schalowitz DI, Miller FG. 2008. Communicating the results of clinical research to participants: attitudes, practices, and future directions. PLoS Med 5:e91.
  • Tonellato PJ, Crawford JM, Boguski MS, Saffitz JE. 2011. A national agenda for the future of pathology in personalized medicine: report of the proceedings of a meeting at the Banbury Conference Center on genome-era pathology, precision diagnostics, and preemptive care: a stakeholder summit. Am J Clin Pathol 135:668672.
  • Vissers LE, de Ligt J, Gilissen C, Janssen I, Steehouwer M, de Vries P, van Lier B, Arts P, Wieskamp N, del Rosario M, van Bon BW, Hoischen A, and many others. 2010. A de novo paradigm for mental retardation. Nat Genet 42:11091112.
  • Welch JS, Westervelt P, Ding L, Larson DE, Klco JM, Kulkarni S, Wallis J, Chen K, Payton JE, Fulton RS, Veizer J, Schmidt H, and many others. 2011. Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. JAMA 305:15771584.